Prediction of the response to citalopram and reboxetine in post-stroke depressed patients: The reasons of the enrollment of patients without cognitive impairment [3]

Psychopharmacology

Volumn 175, Issue 2, 2004, Pages 264-

  Rampello, Liborio ^a   Alvano, Alessandro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; REBOXETINE;

CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CORRELATION ANALYSIS; DEPRESSION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LETTER; MINI MENTAL STATE EXAMINATION; PREDICTION; PRIORITY JOURNAL; STROKE;

EID: 4544324119     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1978-4     Document Type: Letter

References (4)

1. Rampello L, Nicoletti G, Raffaele R (1991) Dopaminergic hypothesis for retarded depression: a symptom profile for predicing therapeutical responses. Acta Psychiatr Scand 84:552-554
2. Rampello L, Nicoletti G, Raffaele R, Drago F (1995) Comparative effects of amitriptyline and amineptine in patients affected by anxious depression. Neuropsychobiology 31:130-134
3. Rampello L, Chiechio S, Nicoletti G, Alvano A, Vecchio I, Raffaele R, Malaguarnera M (2004) Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology 173:73-78
4. Spalletta G, Caltagirone C (2003) Global cognitive level and antidepressant efficacy in post-stroke depression. Psychopharmacology (in press)